Marta Vaz Batista
- Oncology top 10%
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 7
- HER2/EGFR in Cancer Research 4
-
- Brain Metastases and Treatment 14
- Lung Cancer Treatments and Mutations 5
-
- Breast Cancer Treatment Studies 2
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Endometrial and Cervical Cancer Treatments 2
Marta Vaz Batista
22 papers receiving 351 citations
Hit Papers
Peers
Comparison fields: 5 of 45
- Oncology 270
- Pulmonary and Respiratory Medicine 187
- Cancer Research 51
- Genetics 36
- Radiology, Nuclear Medicine and Imaging 47
Countries citing papers authored by Marta Vaz Batista
This map shows the geographic impact of Marta Vaz Batista's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Vaz Batista with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Vaz Batista more than expected).
Fields of papers citing papers by Marta Vaz Batista
This network shows the impact of papers produced by Marta Vaz Batista. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Vaz Batista. The network helps show where Marta Vaz Batista may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marta Vaz Batista, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 7 | |
| 14 | Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trialbreakdown → | 2022 | 162 |
| 15 | 2021 | 85 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 25 | |
| 18 | 2021 | 0 | |
| 19 | 2019 | 2 | |
| 20 | 2019 | 1 |
About Marta Vaz Batista
Marta Vaz Batista is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 28 papers that have together received 358 indexed citations. Recurring topics across this work include Brain Metastases and Treatment (14 papers), Cancer Treatment and Pharmacology (9 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (270 citations), Pulmonary and Respiratory Medicine (187 citations) and Cancer Research (51 citations). Marta Vaz Batista has collaborated with scholars based in Portugal, Spain and Austria. Frequent co-authors include Sofía Braga, Javier Cortés, Laia Garrigós, María Gión, Miguel Sampayo-Cordero, José Manuel Pérez-García, Antonio Llombart‐Cussac, María Fernández, Juan de la Haba-Rodríguez and Salvador Blanch.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.